IQVIA Holdings Inc. (IQV)
NYSE · Healthcare · Medical - Diagnostics & Research
Profile
IQVIA Holdings Inc.
- Exchange
- NYSE
- Ticker
- IQV
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- US
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
Key facts
IQVIA Holdings Inc.: key facts
- IQVIA Holdings Inc. (NYSE: IQV) is a Medical - Diagnostics & Research company in the Healthcare sector.
- In fiscal 2025, IQVIA Holdings Inc. reported revenue of $16.3B and net income of $1.4B.
- Revenue grew 4.1% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 5 of the last 5 fiscal years.
- Over the last twelve months, revenue was $17.3B and net income was $1.4B.
MonkScore
IQVIA Holdings Inc.'s MonkScore
MonkScore
MonkScore range: 70–80
as of October 2026
Sector rank: 153 of 628 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth70–80
- Profitability60–70
- Quality80–90
- Market Conviction70–80
- Safety30–40
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
IQVIA Holdings Inc.'s annual figures and the last twelve months, in USD. Last report: 30 September 2026.
| Figure | Last 12 months | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $17.3B | $16.3B | $15.4B | $15.0B | $14.4B | $13.9B |
| Gross profit | $4.6B | $5.4B | $5.4B | $5.2B | $5.0B | $4.6B |
| Operating income | $2.3B | $2.2B | $2.2B | $2.0B | $1.8B | $1.4B |
| Net income | $1.4B | $1.4B | $1.4B | $1.4B | $1.1B | $966.0M |
| Operating cash flow | $2.7B | $2.7B | $2.7B | $2.1B | $2.3B | $2.9B |
| Capital expenditure | -$657.0M | -$603.0M | -$602.0M | -$649.0M | -$674.0M | -$640.0M |
| Free cash flow | $2.1B | $2.1B | $2.1B | $1.5B | $1.6B | $2.3B |
| Total debt | $16.3B | $16.2B | $14.2B | $13.9B | $13.0B | $12.4B |
| Cash | $2.2B | $2.0B | $1.7B | $1.4B | $1.2B | $1.4B |
Revenue growth a year
- 1-year
- 5.9%
- 3-year
- 4.2%
- 4-year
- 4.1%
Compound growth between fiscal years.
Peers
Similar companies
- Agilent Technologies, Inc.NYSE:AMonkScore range: 70–80
- Mettler-Toledo International Inc.NYSE:MTDMonkScore range: 90–100
- Illumina, Inc.NASDAQ:ILMNMonkScore range: 90–100
- CareDx, IncNASDAQ:CDNAMonkScore range: 90–100
- Medpace Holdings, Inc.NASDAQ:MEDPMonkScore range: 90–100
- IDEXX Laboratories, Inc.NASDAQ:IDXXMonkScore range: 90–100
Compare
Compare with
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.